NCT07470489 2026-04-16Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid CancerM.D. Anderson Cancer CenterPhase 2 Not yet recruiting12 enrolled
NCT06902376 2025-11-05NEO-COMBATXLUNC Lineberger Comprehensive Cancer CenterPhase 1 Recruiting12 enrolled